Pharmazen

[Breezy]

I did notice that there was silence initially around this one. When he asked for someone to second that resolution, nobody responded for some time, until a woman eventually said she would second it. I was expecting at least some discussion after that, but as you say, none was forthcoming. Maybe those present were just not game to speak up? I thought there might be some commentary with regard to the proxy votes - as in, how many voted for or against it, but that didn't happen either. No idea how the presentation of proxy votes works, but I thought it would be done differently.

I didn't bother submitting an online question regarding this because the questions I submitted last year were ignored so couldn't be bothered this time, dare I say that the AGM reminds me very much of an "Old boys club" on the whole.

[Breezy]

Take a look at the depth on the offer side compared to the bids, never mind im sure there will be some staff options up for sale at 25c coming up (Sarcasm intended)

[Monty]

New campaign for AiOra, and new product range, just released:

https://aioranz.com/blogs/news/meet-boh-runga-aiora-creative-director-and-ambassador?utm_source=Klaviyo&utm_medium=campaign&_kx=-QmPWLDRWciaxz4ehS6wfC7mcfImLQJFf1sn7KDRcKs.T7LbhD

Feels a little like desperation to me to be honest.

Aiora is a complete joke....the face of the brand is Boh who?  If I recall correctly it was mentioned in the meeting that Aiora wasnt expect to create huge revenues so why bother doing it?  Is Aiora responsible for the higher than expected marketing costs

[Monty]

I didn't bother submitting an online question regarding this because the questions I submitted last year were ignored so couldn't be bothered this time, dare I say that the AGM reminds me very much of an "Old boys club" on the whole.

I think this company deliberately avoids answering questions and putting out information with any substance behind it.  Alot of spin doctoring goes on for sure.

Only good thing that came out from the meeting was the Chairman stepping down. He should be embarrassed about the way this company has (not) promulgated information, his presentation lacked any enthusiasm, used the word "excited" about the future but certainly didn't exude it.  Shame he is staying on the board.  Hopefully the new Chair will make a difference.  The AGM gave little inspiration and go the sense they were just going through the motions

[Breezy]

I think this company deliberately avoids answering questions and putting out information with any substance behind it.  Alot of spin doctoring goes on for sure.

Only good thing that came out from the meeting was the Chairman stepping down. He should be embarrassed about the way this company has (not) promulgated information, his presentation lacked any enthusiasm, used the word "excited" about the future but certainly didn't exude it.  Shame he is staying on the board.  Hopefully the new Chair will make a difference.  The AGM gave little inspiration and go the sense they were just going through the motions

Are you a holder yourself? Just a big patience game for me, once it hits my avg buy in price I will assess whether or not I can see the company fulfilling anywhere near the potential I think it can or not. Apart from the impacts of Covid the level of the current sp is abysmal to say the least.

[lorraina]

With Rolleston One factory [Tawhiri] due to be operational shortly, new product AiOra launches in Korea and China, together with pet range launch via three online platforms in China,I expect more information will be shared with shareholders in future.
What has never changed is the demand and opportunities for PAZ products.

[lorraina]

Managing Director's agm presentation starts at page 22.
https://prod-trade.usx.co.nz/api/file/667ce944dc9e0482a73b9fa3.pdf

[Breezy]

With Rolleston One factory [Tawhiri] due to be operational shortly, new product AiOra launches in Korea and China, together with pet range launch via three online platforms in China,I expect more information will be shared with shareholders in future.
What has never changed is the demand and opportunities for PAZ products.

Agree with your last sentence but I guess its all about execution at the end of the day, like any athlete having done all the training they have to execute their potential come competition day otherwise its just theoretical.

[Breezy]

Lol someone bidding for 50k shares at 25c, just waiting for those employees keen to ditch there newly minted 25c options.

[Monty]

Are you a holder yourself? Just a big patience game for me, once it hits my avg buy in price I will assess whether or not I can see the company fulfilling anywhere near the potential I think it can or not. Apart from the impacts of Covid the level of the current sp is abysmal to say the least.

Yes, a long time very minor shareholder who has in more recent times started taking notice of what (or isn't) with PAZ.
I am not convinced by the China pet market, their economy is not as buoyant as it used to be so cant see how they expect to succeed when others in the pet product space are feeling the pain.  I am sure I heard it said during the AGM that Aiora wasn't expect to generate high revenues - so why do it?  Is this where marketing costs are up?  Doesn't make sense.

There is a definite trend in the annual reports where a raft of things are reported to be going to happen but very little evidence of execution in subsequent reports.

Time to stop blaming Covid disruption and get on with completing the projects

[Breezy]

Yes, a long time very minor shareholder who has in more recent times started taking notice of what (or isn't) with PAZ.
I am not convinced by the China pet market, their economy is not as buoyant as it used to be so cant see how they expect to succeed when others in the pet product space are feeling the pain.  I am sure I heard it said during the AGM that Aiora wasn't expect to generate high revenues - so why do it?  Is this where marketing costs are up?  Doesn't make sense.

There is a definite trend in the annual reports where a raft of things are reported to be going to happen but very little evidence of execution in subsequent reports.

Time to stop blaming Covid disruption and get on with completing the projects

Has been a very frustrating hold for sure especially with a big holding. I once thought this could be a $3 share but I highly doubt that now and if it snails its way back to $1 in a couple of years that could be as good as it gets. As we all know not every company reaches its true potential and missing the timing to do just that is often the reason.

[lorraina]

Does any one have access to this NBR article and can share it with us.?


NBR

YOUR BUSINESS



Waitaki Biosciences' heavy capital investment starts to pay off



The nutraceutical pioneer is launching its own branded range into China after boosting manufacturing capacity.

[Doozer]

When does the first half result come out?

[lorraina]

Welcome to Stock Talk.

Last year it was on 14th August.
Year before 15th August.

[Breezy]

Result out. Progress but still running on 3 cylinders.